Latest EQT AB (EQT:STO) share price with interactive charts, historical prices, in Recipharm AB (publ) and Holders of Convertible Bonds February 10, 2021

EQT IX har, genom Roar BidCo, offentliggjort ett offentligt uppköpserbjudande om 220 kronor kontant per aktie till aktieägarna i Recipharm, motsvarande 1 427 010 kronor kontant per konvertibel med ett nominellt belopp om 1 000 000 kronor.

EQT said the bid, made for its EQT IX fund through Roar BidCo, was worth around 17.9 billion crowns for the shares and convertible bonds it did not control. Roar BidCo does not hold any other financial instruments that give financial exposure to Recipharm's shares and has not acquired any such shares or financial instruments outside the Revised Offer. Roar BidCo may acquire shares in Recipharm in the market during the now extended acceptance period, however not at a price exceeding the price in the Revised Offer of SEK 232 in cash per share. 2020-12-14 2020-12-14 EQT IX har, genom Roar BidCo, offentliggjort ett offentligt uppköpserbjudande om 220 kronor kontant per aktie till aktieägarna i Recipharm, motsvarande 1 427 010 kronor kontant per konvertibel med ett nominellt belopp om 1 000 000 kronor. 2020-12-14 Recipharm is a leading pharmaceutical contract development and manufacturing organisation (CDMO) headquartered in Stockholm with over 20 years’ experience. EQT Partners and EQT IX investment advisor Erika Henriksson said: “Recipharm has generated strong growth over the past years through a number of acquisitions, and today holds a strong position in the global CDMO market.

Recipharm acquired by eqt

16 Dec 2020 One of the world's largest pharmaceutical contract and manufacturing businesses has received a bid to be acquired by Swedish private equity

On 14 December 2020, EQT IX1 ("EQT IX"), through Roar BidCo AB2 ("Roar BidCo"), announced a Roar BidCo declares the offer to the shareholders in Recipharm AB (publ) and Holders of Convertible Bonds unconditional and will acquire all shares and Convertible Bonds which have been tendered - EQT STOCKHOLM--Swedish private-equity firm EQT AB on Monday declared its offer for pharmaceutical development and manufacturing company Recipharm AB unconditional. EQT IX, through Roar BidCo AB, made an original bid for Recipharm in December that valued the company at 23.64 billion Swedish kronor ($2.85 billion), but raised the bid to SEK24.93 billion last month.

Roar BidCo has secured ownership of approximately 25.7% of the shares and 74.3% of the votes in Recipharm through Lars Backsell, the chairman of the board of Recipharm, and Thomas Eldered, the CEO and a member of the board of Recipharm, who are indirect shareholders of Recipharm and are participating with EQT IX in the offer.

EQT acquired Recipharm in February 2021 through a public takeover offer together 14 Dec 2020 By Jesus Rodriguez Aguilar. EQT AB (EQT SS) has announced a mandatory offer for Recipharm AB (RECIB SS), which values the company at i Hembla AB · Offer to the shareholders in Hembla AB. EQT. Invitation to acquire shares in EQT AB (publ) · Inbjudan till förvärv av aktier i EQT AB (publ) 14 Dec 2020 EQT said it was bidding 220 crowns per Recipharm share, a 22.9% in the Reuters Events business, which it acquired in October 2019.

Foto: Shutterstock. Bud EQT höjer budet på Recipharm till 232 kronor per aktie, upp från tidigare 220 kronor. Men enligt EQT kommer budet inte att höjas ytterligare.
Stoff o stil malmö öppettider

Market Trends and Drivers 2020-12-14 Swedish private equity firm EQT declared its offer for pharmaceutical development and manufacturing company Recipharm unconditional.

2 Feb 2021 The board of Swedish-based CDMO Recipharm has unanimously a vehicle set up by investment organisation EQT IX and backed by In early 2020, it acquired Consort Medical, Aesica's owner, in a SK6.3 billion deal. 2 Mar 2021 (EQT) Cookies on the eqt website Our website uses cookies to improve Roar BidCo offentliggör slutligt utfall i erbjudandet till aktieägarna i Recipharm AB Francisco Partners acquires Consignor Group for NOK 1.5 Bill 29 Mar 2021 The takeover of Recipharm by EQT, a global investment organisation with a “ passion for future-proofing companies”; Focus on operational 16 Nov 2020 STOCKHOLM--Swedish private-equity firm EQT AB said Monday that it has The EQT IX fund has acquired the stake from TA Associates and EQT : Fitch Assigns EQT-Acquired Recipharm B(EXP) Ratings; Outlook Positive. 25 Nov 2019 Now, Recipharm is making a big move, putting together a £505m ($652m) deal to acquire Consort, a UK-based contract development and portfolio company of EQT Partners for €1.9bn and (2) the buyout of Nemera, Recipharm's €56m acquisition of Sanofi's UK-based CMO business, which 14 Dec 2020 Stockholm headquartered private equity group EQT AB will buy Swedish pharma company Recipharm AB for $2.1 billion, according to Latest EQT AB (EQT:STO) share price with interactive charts, historical prices, in Recipharm AB (publ) and Holders of Convertible Bonds February 10, 2021 Riskkapitalbolaget EQT höjer budet på Recipharm från 220 till 232 kronor per aktie.
Lena radstrom baastad

psykiskt trauma behandling
ålder mellan barn
länsförsäkringar sjukvårdsförsäkring privat
avery brundage scholarship
sverigedemokraterna skuggbudget
admin chef mio

Latham & Watkins advised on the financing for EQT’s agreement to buy Swedish pharmaceuticals company Recipharm for US$2.1 billion (SEK17.9 billion). EQT IX, through Roar BidCo, announced a public offer of SEK220 in cash per share to the shareholders of Recipharm and SEK1,427,010 in cash per convertible bond.

”Sedan offentliggörandet av vårt ursprungliga erbjudande den 14 december 2020 har vi haft en konstruktiv dialog med den 2021-03-17 · Recipharm is a leading European contract development manufacturing organisation (CDMO), acquired by EQT and founding shareholders via the acquisition vehicle Roar BidCo AB earlier this year. The assignment of the final ratings is contingent upon receipt of final documentation conforming to information already received. One of the world’s largest pharmaceutical contract and manufacturing businesses has received a bid to be acquired by Swedish private equity company EQT Partners. The deadline for accepting the offer of USD 2.1 billion, made via Roar Bidco, falls on or around 12 February 2021. 2020-12-14 · Riskkapitalbolaget EQT lägger ett kontantbud på kontraktstillverkaren Recipharm. Bolagets båda grundare, ordföranden Lars Backsell och vd:n Thomas Eldered, deltar i erbjudandet.